Percutaneous treatment of atrial septal defects, muscular ventricular septal defects and patent ductus arteriosus in infants under one year of age.
Amplatzer devices are used for the percutaneous closure of ostium secundum atrial septal defects, muscular ventricular septal defects and patent ductus arteriosus. However, very little experience has been gained in using these devices in infants under 1 year of age. Between January 2001 and January 2008, 22 symptomatic infants aged under 1 year underwent percutaneous treatment: three had an ostium secundum atrial septal defect, 15 had patent ductus arteriosus, and four had a muscular ventricular septal defect. All the procedures were completed successfully. No immediate or medium-term complications were observed. Closure of these types of defect using an Amplatzer device in infants under 1 year of age, who would otherwise require surgery, is a safe and effective procedure.
Prada
Fredy
F
Servicio de Cardiología, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, España. fprada@hsjdbcn.org
Mortera
Carlos
C
Bartrons
Joaquim
J
Rissech
Miguel
M
Jiménez
Lorenzo
L
Carretero
Juan
J
Llevadias
Judit
J
Araica
Mireya
M
D004374:Ductus Arteriosus, Patent / Q000601:surgery*; D006344:Heart Septal Defects, Atrial / Q000601:surgery*; D006345:Heart Septal Defects, Ventricular / Q000601:surgery*; D006801:Humans; D007223:Infant; D012189:Retrospective Studies; D055989:Septal Occluder Device